An additional challenge is the growing prevalence of terbinafine resistance, commonly associated with mutations in the squalene epoxidase (SQLE) gene, prompting consideration of alternative therapies for recalcitrant onychomycosis [9,10]. This evidence concerns the gene SQLE and tinea unguium.